Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.62 |
| ▸ | GAA | P10253 | 1/20 | 0.62 |
| ▸ | TP53 | P04637 | 5/20 | 0.61 |
| ▸ | THRB | P10828 | 2/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 4/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | KDR | P35968 | 1/20 | 0.50 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17552189 | 0.86 | MAPT (0.74) | MAPTGAATP53THRBALDH1A1 | |
| SCHEMBL29911131 | 0.86 | MAPT (0.74) | MAPTGAATP53THRBALDH1A1 | |
| SCHEMBL29911020 | 0.83 | MAPT (0.62) | MAPTGAATP53THRBALDH1A1 | |
| SCHEMBL17552232 | 0.83 | MAPT (0.62) | MAPTGAATP53THRBALDH1A1 | |
| SCHEMBL17552242 | 0.82 | GAA (0.67) | MAPTGAATP53THRBALDH1A1 | |
| SCHEMBL29911215 | 0.82 | GAA (0.67) | MAPTGAATP53THRBALDH1A1 | |
| SCHEMBL29911281 | 0.82 | ALDH1A1 (0.57) | MAPTGAATP53THRBALDH1A1 | |
| SCHEMBL17552224 | 0.82 | ALDH1A1 (0.57) | MAPTGAATP53THRBALDH1A1 | |
| SCHEMBL17552233 | 0.81 | MAPT (0.62) | MAPTGAATP53THRBALDH1A1 | |
| SCHEMBL29911123 | 0.81 | MAPT (0.62) | MAPTGAATP53THRBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0876345-B1 | HETEROCYCLIC COMPOUNDS AS H+-ATPASES | FUJISAWA PHARMACEUTICAL CO (JP) | 2004-08-18 | — | — | EP | disclosed |
| US-6008230-A | TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-12-28 | — | — | US | disclosed |
| EP-0876345-A1 | HETEROCYCLIC COMPOUNDS AS H+-ATPASES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-11-11 | — | — | EP | disclosed |
| WO-1997014681-A1 | HETEROCYCLIC COMPOUNDS AS H+-ATPASES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-04-24 | — | — | WO | disclosed |